litlas
Log inCreate account

Matthias Ernst

Active 1988–2025

156
Papers
21,872
Citations
87
h-index
145
i10-index

Citations

Citations per year for Matthias Ernst1989: 11 citations1990: 22 citations1991: 28 citations1992: 39 citations1993: 41 citations1994: 24 citations1995: 33 citations1996: 23 citations1997: 35 citations1998: 42 citations1999: 23 citations2000: 25 citations2001: 30 citations2002: 37 citations2003: 51 citations2004: 63 citations2005: 94 citations2006: 147 citations2007: 184 citations2008: 280 citations2009: 265 citations2010: 269 citations2011: 261 citations2012: 234 citations2013: 252 citations2014: 252 citations2015: 259 citations2016: 257 citations2017: 226 citations2018: 237 citations2019: 714 citations2020: 821 citations2021: 852 citations2022: 709 citations2023: 568 citations2024: 754 citations2025: 425 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,612 citing papers, 24.4% of this breakdownChina: 1,605 citing papers, 15% of this breakdownGermany: 817 citing papers, 7.6% of this breakdownUnited Kingdom: 603 citing papers, 5.6% of this breakdownAustralia: 576 citing papers, 5.4% of this breakdownJapan: 418 citing papers, 3.9% of this breakdownFrance: 388 citing papers, 3.6% of this breakdownItaly: 355 citing papers, 3.3% of this breakdownCanada: 292 citing papers, 2.7% of this breakdownSwitzerland: 231 citing papers, 2.2% of this breakdownSouth Korea: 201 citing papers, 1.9% of this breakdownNetherlands: 195 citing papers, 1.8% of this breakdown
0%24.4%Other 22.6%

Institutions

Fields

  • Medicine41.5%
  • Biochemistry, Genetics and Molecular Biology27.7%
  • Immunology and Microbiology18.4%
  • Neuroscience3.3%
  • Chemistry2.9%
  • Computer Science2.1%
  • Other4.1%

Topics

  • Cytokine Signaling Pathways and Interactions5.3%
  • Immune Cell Function and Interaction3%
  • Immune cells in cancer2.9%
  • Cancer Immunotherapy and Biomarkers1.8%
  • T-cell and B-cell Immunology1.7%
  • Immune Response and Inflammation1.6%
  • Other83.7%

Coauthors

All papers

Open in search
  1. Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map

    Authors: Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, Matthias Ernst - Nature reviews. Cancer 2018 cited by 521

  2. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies

    Authors: Ibraheem Nasir, Conor McGuinness, Ashleigh R. Poh, Matthias Ernst, Phillip K. Darcy, Kara L. Britt - Trends in Immunology 2023 cited by 138

  3. 5S Study: Safe and Simple Single Shot Pulmonary Vein Isolation With Pulsed Field Ablation Using Sedation

    Authors: Boris Schmidt, Stefano Bordignon, Shota Tohoku, Shaojie Chen, Fabrizio Bologna, Lukas Urbanek, Francesco Pansera, Matthias Ernst, K. R. Julian Chun - Circulation Arrhythmia and Electrophysiology 2022 cited by 140

  4. Targeting Macrophages in Cancer: From Bench to Bedside

    Authors: Ashleigh R. Poh, Matthias Ernst - Frontiers in Oncology 2018 cited by 520

  5. RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis

    Authors: James A. Rickard, Joanne A. O’Donnell, Joseph M. Evans, Najoua Lalaoui, Ashleigh R. Poh, TeWhiti Rogers, James E. Vince, Kate E. Lawlor, Robert L. Ninnis, Holly Anderton, Cathrine Hall, Sukhdeep K. Spall, Toby J. Phesse, Helen E. Abud, Louise H. Cengia, Jason Corbin, Sandra Mifsud, Ladina Di Rago, Donald Metcalf, Matthias Ernst, Grant Dewson, Andrew W. Roberts, Warren S. Alexander, James M. Murphy, Paul G. Ekert, Seth L. Masters, David L. Vaux, Ben A. Croker, Motti Gerlic, John Silke - Cell 2014 cited by 598

  6. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization

    Authors: Moritz F. Eissmann, Christine D. Dijkstra, Andrew Jarnicki, Toby J. Phesse, Jamina Brunnberg, Ashleigh R. Poh, Nima Etemadi, Evelyn Tsantikos, Stefan Thiem, Nicholas D. Huntington, Margaret L. Hibbs, Alex Boussioutas, Michele A. Grimbaldeston, Michael Büchert, Robert J.J. O’Donoghue, Frédérick Masson, Matthias Ernst - Nature Communications 2019 cited by 232

  7. gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

    Authors: Julia Bollrath, Toby J. Phesse, Vivian A. von Burstin, Tracy L. Putoczki, Moritz Bennecke, Trudie Bateman, Tim Nebelsiek, Therése Lundgren–May, Özge Canli, Sarah Schwitalla, Vance B. Matthews, Roland M. Schmid, Thomas Kirchner, Melek C. Arkan, Matthias Ernst, Florian R. Greten - Cancer Cell 2009 cited by 939

  8. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges

    Authors: Ashleigh R. Poh, Matthias Ernst - Cancers 2021 cited by 96

  9. STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential

    Authors: Sarah Q. To, Rhynelle S. Dmello, Anna K. Richards, Matthias Ernst, Ashwini L. Chand - Cancers 2022 cited by 83

  10. IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3

    Authors: Ceri A. Fielding, Rachel M. McLoughlin, Louise McLeod, Chantal S. Colmont, Meri Najdovska, Dianne Grail, Matthias Ernst, Simon A. Jones, Nicholas Topley, Brendan J. Jenkins - The Journal of Immunology 2008 cited by 408

  11. Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis

    Authors: Paul K. Ziegler, Julia Bollrath, Charles Pallangyo, Takaji Matsutani, Özge Canli, Tiago De Oliveira, Michaela A. Diamanti, Nina Müller, Jaba Gamrekelashvili, Tracy L. Putoczki, David Horst, Arun K. Mankan, Meryem Gülfem Öner, Susanna Müller, Josef Müller‐Höcker, Thomas Kirchner, Julia Slotta‐Huspenina, Makoto M. Taketo, Thomas Reinheckel, Stefan Dröse, Andrew C. Larner, Winfried S. Wels, Matthias Ernst, Tim F. Greten, Melek C. Arkan, Thomas Korn, Dagmar Wirth, Florian R. Greten - Cell 2018 cited by 158

  12. IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3

    Authors: Claire Greenhill, Stefan Rose‐John, Rami Lissilaa, Walter Ferlin, Matthias Ernst, Paul J. Hertzog, Ashley Mansell, Brendan J. Jenkins - The Journal of Immunology 2010 cited by 266

  13. The JAK/STAT3 axis: A comprehensive drug target for solid malignancies

    Authors: Jennifer Huynh, Nima Etemadi, Frédéric Hollande, Matthias Ernst, Michael Büchert - Seminars in Cancer Biology 2017 cited by 202

  14. Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically

    Authors: Tracy L. Putoczki, Stefan Thiem, Andrea Loving, Rita A. Busuttil, Nicholas J. Wilson, Paul K. Ziegler, Paul M. Nguyen, Adele Preaudet, Ryan Farid, Kirsten M. Edwards, Yeliz Boglev, Rodney B. Luwor, Andrew Jarnicki, David Horst, Alex Boussioutas, Joan K. Heath, Oliver M. Sieber, Irina Pleines, Benjamin T. Kile, Andrew D. Nash, Florian R. Greten, Brent S. McKenzie, Matthias Ernst - Cancer Cell 2013 cited by 425

  15. Repurposing of drugs as STAT3 inhibitors for cancer therapy

    Authors: Pathum Thilakasiri, Rhynelle S. Dmello, Tracy L. Nero, Michael W. Parker, Matthias Ernst, Ashwini L. Chand - Seminars in Cancer Biology 2019 cited by 110

  16. Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis

    Authors: Cecilia M. Prêle, Tylah Miles, David R. Pearce, Robert J.J. O’Donoghue, Christopher Grainge, Lucy Barrett, Kimberly A. Birnie, Andrew Lucas, Svetlana Baltic, Matthias Ernst, Catherine Rinaldi, Geoffrey J. Laurent, Darryl A. Knight, Mark W. Fear, Gerard F. Hoyne, Robin J. McAnulty, Steven E. Mutsaers - European Respiratory Journal 2022 cited by 71

  17. Frizzled7 Functions as a Wnt Receptor in Intestinal Epithelial Lgr5+ Stem Cells

    Authors: Dustin J. Flanagan, Toby J. Phesse, Nick Barker, Renate Schwab, Nancy Amin, Jordane Malaterre, Daniel E. Stange, Cameron J. Nowell, S. Currie, Jarel T.S. Saw, Eva Beuchert, Robert G. Ramsay, Owen J. Sansom, Matthias Ernst, Hans Clevers, Elizabeth Vincan - Stem Cell Reports 2015 cited by 140

  18. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer

    Authors: Xing Zhang, Mohammed Soutto, Zheng Chen, Nadeem S. Bhat, Shoumin Zhu, Moritz F. Eissmann, Matthias Ernst, Heng Lu, Dunfa Peng, Zekuan Xu, Wael El‐Rifai - Gastroenterology 2022 cited by 63

  19. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system

    Authors: Jason S. Stumhofer, Arian Laurence, Emma H. Wilson, Elaine Huang, Cristina M. Tato, Leanne M. Johnson, Alejandro V. Villarino, Qiulong Huang, Akihiko Yoshimura, David Sehy, Christiaan J. M. Saris, John J. O’Shea, Lothar Hennighausen, Matthias Ernst, Christopher A. Hunter - Nature Immunology 2006 cited by 942

  20. A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet

    Authors: Annie Xin, Frédérick Masson, Yang Liao, Simon Preston, Tianxia Guan, Renee Gloury, Moshe Olshansky, Jian-Xin Lin, Peng Li, Terence P. Speed, Gordon K. Smyth, Matthias Ernst, Warren J. Leonard, Marc Pellegrini, Susan M. Kaech, Stephen L. Nutt, Wei Shi, Gabrielle T. Belz, Axel Kallies - Nature Immunology 2016 cited by 179

  21. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism

    Authors: Virginie Deswaerte, Paul M. Nguyen, Alison C. West, Alison F. Browning, Liang Yu, Saleela M. Ruwanpura, Jesse J. Balic, Thaleia Livis, Charlotte Girard, Adele Preaudet, Hiroko Oshima, Ka Yee Fung, Hazel Tye, Meri Najdovska, Matthias Ernst, Masanobu Oshima, Cem Gabay, Tracy L. Putoczki, Brendan J. Jenkins - Cancer Research 2017 cited by 82

  22. Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities

    Authors: Sagun Parakh, Matthias Ernst, Ashleigh R. Poh - Cancers 2021 cited by 65

  23. STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice

    Authors: Matthias Ernst, Meri Najdovska, Dianne Grail, Therése Lundgren–May, Michael Büchert, Hazel Tye, Vance B. Matthews, Jane E. Armes, Prithi S. Bhathal, Norman R. Hughes, Eric G. Marcusson, James G. Karras, Songqing Na, Jonathon D. Sedgwick, Paul J. Hertzog, Brendan J. Jenkins - Journal of Clinical Investigation 2008 cited by 352

  24. A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development

    Authors: Ryan O’Keefe, Annalisa L. E. Carli, David Baloyan, David Chisanga, Wei Shi, Shoukat Afshar‐Sterle, Moritz F. Eissmann, Ashleigh R. Poh, Bhupinder Pal, Cyril Seillet, Richard M. Locksley, Matthias Ernst, Michael Büchert - Nature Communications 2023 cited by 43